Literature DB >> 2501357

Cleavage of procaryotically expressed human immunodeficiency virus fusion proteins by factor Xa and application in western blot (immunoblot) assays.

S Ellinger1, R Glockshuber, G Jahn, A Plückthun.   

Abstract

The proteins p15 and p24 of the human immunodeficiency virus (HIV) type 1 gag gene were expressed as fusion proteins in Escherichia coli for detecting antibodies against the acquired immunodeficiency virus by Western blot (immunoblot) analysis. These fusion proteins contain amino acids 1 to 375 of the E. coli beta-galactosidase linked to the viral protein(s) by a recognition sequence for the specific protease factor Xa. They are obtained in large amounts in insoluble inclusion bodies. To avoid ambiguous results caused by cross-reaction of sera with bacterial proteins in Western blots, we purified the recombinant fusion proteins and subsequently removed the bacterial part of the fusions by cleavage with factor Xa. The cleavage mixtures were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and blotted onto nitrocellulose membranes. The viral proteins obtained by this method did not contain any bacterial proteins or protein fragments. Thus, false-positive results in HIV Western blot analysis with bacterially expressed HIV proteins can be excluded with these purified recombinant viral antigens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501357      PMCID: PMC267465          DOI: 10.1128/jcm.27.5.971-976.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

2.  Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients.

Authors:  M Alizon; S Wain-Hobson; L Montagnier; P Sonigo
Journal:  Cell       Date:  1986-07-04       Impact factor: 41.582

3.  Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.

Authors:  J J Wang; S Steel; R Wisniewolski; C Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

5.  Differential antibody responses of individuals infected with AIDS-associated retroviruses surveyed using the viral core antigen p25gag expressed in bacteria.

Authors:  K S Steimer; J P Puma; M D Power; M A Powers; C George-Nascimento; J C Stephans; J A Levy; R Sanchez-Pescador; P A Luciw; P J Barr
Journal:  Virology       Date:  1986-04-15       Impact factor: 3.616

6.  Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human sera.

Authors:  J Ghrayeb; I Kato; S McKinney; J J Huang; P K Chanda; D D Ho; M G Sarangadharan; T W Chang; N T Chang
Journal:  DNA       Date:  1986-04

7.  Expression of the art gene protein of human T-lymphotropic virus type III (HTLV-III/LAV) in bacteria.

Authors:  W C Goh; J G Sodroski; C A Rosen; W A Haseltine
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

8.  Polymer support oligonucleotide synthesis XVIII: use of beta-cyanoethyl-N,N-dialkylamino-/N-morpholino phosphoramidite of deoxynucleosides for the synthesis of DNA fragments simplifying deprotection and isolation of the final product.

Authors:  N D Sinha; J Biernat; J McManus; H Köster
Journal:  Nucleic Acids Res       Date:  1984-06-11       Impact factor: 16.971

9.  Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea.

Authors:  S P Fling; D S Gregerson
Journal:  Anal Biochem       Date:  1986-05-15       Impact factor: 3.365

10.  Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus.

Authors:  J W Gnann; P L Schwimmbeck; J A Nelson; A B Truax; M B Oldstone
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

View more
  13 in total

1.  Characterization of coronavirus RNA polymerase gene products.

Authors:  J Herold; S Siddell; J Ziebuhr
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

2.  Characterization and localization of the KpsE protein of Escherichia coli K5, which is involved in polysaccharide export.

Authors:  C Rosenow; F Esumeh; I S Roberts; K Jann
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

3.  In vitro binding of human T-cell leukemia virus rex proteins to the rex-response element of viral transcripts.

Authors:  R Grassmann; S Berchtold; C Aepinus; C Ballaun; E Boehnlein; B Fleckenstein
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Functional analysis of human foamy virus accessory reading frames.

Authors:  G Baunach; B Maurer; H Hahn; M Kranz; A Rethwilm
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

5.  Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat.

Authors:  B Maurer; E Serfling; V ter Meulen; A Rethwilm
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  Gene for the major antigenic structural protein (p100) of human herpesvirus 6.

Authors:  F Neipel; K Ellinger; B Fleckenstein
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.

Authors:  M Urban; W Britt; M Mach
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

8.  Characterization of a human coronavirus (strain 229E) 3C-like proteinase activity.

Authors:  J Ziebuhr; J Herold; S G Siddell
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus.

Authors:  S M Lang; M Weeger; C Stahl-Hennig; C Coulibaly; G Hunsmann; J Müller; H Müller-Hermelink; D Fuchs; H Wachter; M M Daniel
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice.

Authors:  A Aguzzi; E F Wagner; K O Netzer; K Bothe; I Anhauser; A Rethwilm
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.